Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

537 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 DeltaicsA Deltaent Deltafep DeltastxA:HgR oral vaccine SC599 in healthy human adult volunteers.
Sadorge C, Ndiaye A, Beveridge N, Frazer S, Giemza R, Jolly N, Johnson J, Liddy H, Cosgrove CA, Allavena P, Mantovani A, Béchet S, Fontaine-Thompson A, Griffin GE, Dupont F, Sansonetti PJ, Lewis DJ. Sadorge C, et al. Among authors: ndiaye a. Vaccine. 2008 Feb 13;26(7):978-87. doi: 10.1016/j.vaccine.2007.11.024. Epub 2007 Dec 3. Vaccine. 2008. PMID: 18207287 Clinical Trial.
Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trial.
Launay O, Sadorge C, Jolly N, Poirier B, Béchet S, van der Vliet D, Seffer V, Fenner N, Dowling K, Giemza R, Johnson J, Ndiaye A, Vray M, Sansonetti P, Morand P, Poyart C, Lewis D, Gougeon ML. Launay O, et al. Among authors: ndiaye a. Vaccine. 2009 Feb 18;27(8):1184-91. doi: 10.1016/j.vaccine.2008.12.021. Epub 2009 Jan 9. Vaccine. 2009. PMID: 19135496 Clinical Trial.
SC599 vaccine is a live Shigella dysenteriae 1 strain attenuated by deletion of invasion [icsA], iron chelation [ent, fep] and shiga toxin A subunit [stxA] genes. In a preliminary Phase 1 single dose prospective study, we showed that SC599 vaccine was well to …
SC599 vaccine is a live Shigella dysenteriae 1 strain attenuated by deletion of invasion [icsA], iron chelation [ent, fep] and shiga …
Hepatitis B in Senegal: A Successful Infant Vaccination Program but Urgent Need to Scale Up Screening and Treatment (ANRS 12356 AmBASS survey).
Périères L, Diallo A, Marcellin F, Nishimwe ML, Ba EH, Coste M, Lo G, Halfon P, Touré Kane C, Maradan G, Carrieri P, Diouf A, Shimakawa Y, Sokhna C, Boyer S; ANRS 12356 AmBASS Survey Study Group. Périères L, et al. Hepatol Commun. 2022 May;6(5):1005-1015. doi: 10.1002/hep4.1879. Epub 2021 Dec 17. Hepatol Commun. 2022. PMID: 34918868 Free PMC article.
Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in Senegal.
Toyé RM, Lô G, Diop-Ndiaye H, Cissé AM, Ndiaye AJS, Kébé-Fall K, Dramé A, Cohen D, Pujol FH, Mboup S, Boye CS, Chemin I, Laborde-Balen G, Taverne B, Touré-Kane C. Toyé RM, et al. Among authors: ndiaye ajs. Clin Res Hepatol Gastroenterol. 2021 Mar;45(2):101502. doi: 10.1016/j.clinre.2020.07.007. Epub 2020 Aug 20. Clin Res Hepatol Gastroenterol. 2021. PMID: 32828748
Heterogeneity of the Omicron variant in Senegal.
Diédhiou CK, Padane A, Gueye K, Ndiour S, Mboup A, Mbow M, Lo CI, Leye N, Sow Ndoye A, Ndiaye AJS, Diagne ND, Ndiaye S, Dia YA, Lo G, Wade D, Diaw PA, Sarr M, Beye M, Cissé B, Sokhna C, Camara M, Ahouidi A, Touré Kane NC, Mboup S. Diédhiou CK, et al. Among authors: ndiaye s, ndiaye ajs. New Microbes New Infect. 2022 May 28;47:100990. doi: 10.1016/j.nmni.2022.100990. eCollection 2022 Apr-May. New Microbes New Infect. 2022. PMID: 35747620 Free PMC article.
Comparison of Amplix® hepatitis B virus and Roche COBAS AmpliPrep/COBAS Taqman hepatitis B virus assay in quantifying HBV DNA in plasma of chronic hepatitis B in Senegal.
Lô G, Ndiaye AJS, Sow A, Fall A, Sow A, Barry O, Diop NM, Ndiaye HD, Kâne NCT, Mboup S. Lô G, et al. Among authors: ndiaye hd, ndiaye ajs. Pan Afr Med J. 2021 Mar 22;38:294. doi: 10.11604/pamj.2021.38.294.24819. eCollection 2021. Pan Afr Med J. 2021. PMID: 34178213 Free PMC article.
Correction: A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.
Penfold S, Adegnika AA, Asogun D, Ayodeji O, Azuogu BN, Fischer WA 2nd, Garry RF, Grant DS, Happi C, N'Faly M, Olayinka A, Samuels R, Sibley J, Wohl DA, Accrombessi M, Adetifa I, Annibaldis G, Camacho A, Dan-Nwafor C, Deha ARE, DeMarco J, Duraffour S, Goba A, Grais R, Günther S, Honvou ÉJJP, Ihekweazu C, Jacobsen C, Kanneh L, Momoh M, Ndiaye A, Nsaibirni R, Okogbenin S, Ochu C, Ogbaini E, Logbo ÉPMA, Sandi JD, Schieffelin JS, Verstraeten T, Vielle NJ, Yadouleton A, Yovo EK; Enable Protocol authorship group. Penfold S, et al. Among authors: ndiaye a. PLoS One. 2025 Jan 14;20(1):e0317720. doi: 10.1371/journal.pone.0317720. eCollection 2025. PLoS One. 2025. PMID: 39808605 Free PMC article.
537 results